|
Healthcare financing by India's fintech platforms is helping close the treatment access gap by making quality healthcare more affordable, timely, and accessible. By offering flexible payment options, digital lending solutions, and simplified financing processes, these platforms are enabling more patients to begin and continue essential treatments without being held back by upfront medical costs.
Gaurav Gupta, co-founder & CEO, CarePay, said India has a healthcare problem that rarely makes headlines. It is the treatment drop-off, because of the cost. Now the treatment drop-off is fundamentally a cash-flow problem wearing a healthcare disguise. The patient is not saying they cannot afford the treatment over time. They are saying they cannot absorb it as a single transaction, right now, today. These are different problems, and they require different solutions.
Equated monthly instalment or EMI-based patient financing addresses the gap that insurance does not reach. A procedure costing Rs. 60,000 spread across twelve months at zero cost becomes Rs. 5,000 a month, a number that fits within most middle-income household budgets without disruption. The treatment happens. The health outcome follows. The financial burden is managed across a timeline the household can actually navigate, he added.
Clinics that have introduced structured financing at the point of consultation are consistently finding that conversion rates improve and drop-off falls. The patient who would have said they need to think about it and never returned is now completing the booking before leaving the clinic. The intervention is not medical. It is financial. But the outcome it enables is entirely medical, said Gupta.
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana scheme has done meaningful work here. But coverage has limits. The scheme covers inpatient hospitalisation for eligible beneficiaries. It does not cover the large and growing category of elective, planned, and outpatient procedures where treatment drop-off is most acute. Dental procedures, dermatology treatments, fertility interventions, elective surgeries, diagnostic packages: this is the territory where patients with genuine medical need are most likely to defer because no scheme is there to bridge the gap and the upfront cost is real, Gupta said.
India's progress on healthcare financing over the last decade is indisputable. Government spending has risen. Insurance coverage has expanded. Out-of-pocket expenditure has fallen as a share of total health spending. India has built the hospitals, trained the doctors, and created the demand. The missing piece is not clinical but is financial. Closing that gap, one approval at a time, may turn out to be one of the most consequential things the healthcare sector does this decade, he said.
The scale of this problem has been quantified. A nationwide survey by CarePay across 3,100 clinics found that six in ten patients leave without undergoing treatment after their initial consultation, with financial liquidity constraints cited as the primary driver rather than any lack of intent. A clinic running 100 consultations a week and losing 40 to 60 of those at the payment stage is not experiencing a clinical failure. It is experiencing a financial one, repeated every single week, said Gupta.
|